Fact CheckerSign in

NCT05911269Completed

Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors

Determining the Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors

Source: ClinicalTrials.gov · Last updated 28 Jul 2026

Brief summary (registry, in English)

Demonstrate the feasibility of conducting an eight-week, (45 min/week), theory driven, virtually-delivered, tailored music-based relaxation (TiMBRe) intervention to decrease anxiety in adolescent and young adult (AYA) cancer survivors with clinically-relevant anxiety.

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
12 Jun 2023
Start date
21 Jan 2025
Primary completion date
24 Jul 2026
Lead sponsor
University of Michigan Rogel Cancer Center
NCT number
NCT05911269

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 21 Jan 2025 to the primary completion date, 24 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • plans in place to begin new psychosocial (i.e., cognitive behavioral therapy14 or mindfulness-based stress reduction15) or pharmacological treatments for anxiety during the study. Although, participants may continue psychosocial or pharmacological treatments for anxiety if the treatments were initiated at least eight weeks prior to study enrollment, the dose has not changed, and they report clinically relevant anxiety in the last week.

Other illness

  • documentation of significant hearing impairment
  • plan to receive surgery, radiation, or chemotherapy for cancer treatment during the study period

Other

  • prognosis less than 3 months

Who the study is looking for

  • 15 - 39 years old
  • at least one month post cancer treatment
  • report clinically relevant anxiety in the past seven days (PROMIS Anxiety 4a scores ≥ 55)35
  • speak/read English.

Age in the registry: 15 years to 39 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Michigan
Coordinator of this site? Confirm its status
Ann ArborUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.